Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

1.18
Delayed Data
As of Jun 23
 -0.01 / -0.84%
Today’s Change
0.73
Today|||52-Week Range
8.49
-6.35%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close1.19
Today’s open1.20
Day’s range1.13 - 1.21
Volume12,273,959
Average volume (3 months)6,680,101
Market cap$333.5M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+40.40%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MRUSMerus NV+0.73+4.39%
SELBSelecta Biosciences ...+1.14+6.88%
RIGLRigel Pharmaceutical...+0.02+0.72%
AGENAgenus Inc-0.05-1.24%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts